T1/T2 glottic cancer managed by external beam radiotherapy: The influence of pretreatment hemoglobin on local control

International Journal of Radiation Oncology Biology Physics

Volumn 41, Issue 2, 1998, Pages 347-353

  Warde, Padraig ^a   O'Sullivan, Brian ^a   Bristow, Robert G ^a   Panzarella, Tony ^a   Keane, Thomas J ^a   Gullane, Patrick J ^a   Witterick, Ian P ^a   Payne, David ^a   Liu, Fei Fei ^a   McLean, Michael ^a   Waldron, John ^a   Cummings, Bernard J ^a  

^a PRINCESS MARGARET HOSPITAL   (Canada)

Author keywords

Glottic cancer; Hemoglobin; Local control; Radiation therapy

Indexed keywords

HEMOGLOBIN;

ADULT; AGED; ARTICLE; CANCER CONTROL; CANCER INVASION; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; EPIGLOTTIS CANCER; FEMALE; GENDER; HEMOGLOBIN DETERMINATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; TUMOR VOLUME;

EID: 18144445588     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(98)00062-5     Document Type: Article

References (35)

1. O'Sullivan B., Mackillop W., Gilbert R., Gaze M., Lundgren J., Atkinson C., Wynne C., Fu H. Controversies in the management of laryngeal cancer Results of an international survey of patterns of care . Radiother. Oncol. 31:1994;23-32.
2. Lusinchi A., Dube P., Wibault P., Kunkler I., Luboinski B., Eshwege F. Radiation therapy in the treatment of early glottic carcinoma The experience of Villejuif . Radiother. Oncol. 15:1989;313-319.
3. Mendenhall W.M., Parsons J.T., Million R.R. Management of T1 and T2 squamous cell carcinoma of the glottic larynx [editorial]. Mayo Clinic Proc. 67:(7):1992;703-705.
4. Sakata K., Aoki Y., Karasawa K., Hasezawa K., Muta N., Nakagawa K., Terahara A., Onogi Y., Sasaki Y., Akanuma A. Radiation therapy in early glottic carcinoma Uni- and multivariate analysis of prognostic factors affecting local control . Int. J. Radiat. Oncol. Biol. Phys. 30:(5):1994;1059-1064.
5. Stevens G., Castle G., O'Brien C.J. Treatment of early carcinoma of the vocal cords by radiotherapy. Australas. Radiol. 38:(2):1994;119-122.
6. Eiband J., Elias E., Suter C., Gray W., Didolkar M. Prognostic factors in squamous cell carcinoma of the larynx. Am. J. Surg. 158:1989;314-317.
7. Fein D.A., Mendenhall W.M., Parsons J.T., Million R.R. T1-T2 squamous cell carcinoma of the glottic larynx treated with radiotherapy A multivariate analysis of variables potentially influencing local control . Int. J. Radiat. Oncol. Biol. Phys. 25:(4):1993;605-611.
8. Harwood A. Cancer of the larynx - the Toronto experience. J. Otolaryngol. 11:(Suppl. 11):1982;1-21.
9. Johansen L., Overgaard J., Hjelm-Hansen M., Gadeberg C. Primary radiotherapy of T1 squamous cell carcinoma of the larynx Analysis of 478 patients treated from 1963 to 1985 . Int. J. Radiat. Oncol. Biol. Phys. 18:1990;1307-1313.
10. Bush R., Jenkin R., Allt W.E. Definitive evidence for hypoxic cells influencing cure in cancer therapy. Br. J. Cancer. 37:1978;302-306.
11. Dische S., Anderson P., Sealy R. Carcinoma of the cervix - anaemia, radiotherapy and hyperbaric oxygen. Br. J. Radiol. 56:1983;251-255.
12. Hirst D. What is the importance of anemia in radiotherapy? The value of animal studies. Radiother. Oncol. 20:(Suppl. 1):1991;29-33.
13. Fein D., Lee W., Hanlon A., Ridge J., Langer C., Curran W., Coia L. Pretreatment hemoglobin level influences local control and survival of T1-T2 squamous cell carcinomas of the glottic larynx. J. Clin. Oncol. 13:(8):1995;2077-2083.
14. Tarnawski R., Skladowski K., Maciejewski B. Prognostic value of hemoglobin concentration in radiotherapy for cancer of supraglottic larynx. Int. J. Radiat. Oncol. Biol. Phys. 8:1997;1007-1011.
15. Cox D. Regression models and lifetables. J. R. Stat. Soc. Series B. 34:1972;187-220.
16. Collett D. Modelling survival data in medical research. 1994;Chapman and Hall, London.
17. Kaplan E., Meier P. Nonparametric estimation from incomplete observations. J. Am. Stat. Assoc. 53:1958;457-481.
18. SAS/STAT User's guide, version 6. 4th ed., Vol. 1. Cary, NC: SAS Institute Inc.; 1989.
19. SAS/STAT User's guide, version 6. 4th ed., Vol. 2. Cary, NC: SAS Institute, Inc.; 1989.
20. S-PLUS User's manual. Vol. 2. Seattle: Statistical Sciences, Inc.; 1991.
21. Vigario G., Kurohara S., George F. Association of hemoglobin levels before and during radiotherapy with prognosis in uterine cervix cancer. Radiology. 106:1973;649-652.
22. Bentzen S., Johansen L., Overgaard J. Clinical radiobiology of squamous cell carcinoma of the oropharynx. Int. J. Radiat. Oncol. Biol. Phys. 20:1991;1197-1206.
23. Overgaard J. The influence of haemoglobin concentration on the response to radiotherapy. Scan. J. Clin. Lab. Invest. 48:1988;49-53.
24. Hill R., Yeung P., Bush R. The effect of anaemia on the fraction of hypoxic cells in an experimental tumour. Br. J. Radiol. 44:1971;299-304.
25. Brizel D., Scully S., Harrelson J., Layfield L., Bean J., Prosnitz L., Dewhirst M. Tumor oxygenation predicts for the likelihood of distant metastases in human soft tissue sarcoma. Cancer Res. 56:1996;941-943.
26. Hockel M., Schlenger K., Aral B., Mitze M., Schaffer U., Vaupel P. Association between tumour hypoxia and malignant progression in advanced cancer of the uterine cervix. Cancer Res. 56:1996;4509-4515.
27. van Acht M., Hermans J., Boks D., Leer J. The prognostic value of hemoglobin and a decrease in hemoglobin during radiotherapy in laryngeal carcinoma. Radiother. Oncol. 23:1992;229-253.
28. Gulledge C., Dewhirst M. Tumor oxygenation A matter of supply and demand . Anticancer Res. 16:1996;741-749.
29. Degner F., Sutherland R. Mathematical modelling of oxygen supply and oxygenation in tumor tissues Prognostic, therapeutic and experimental implications . Int. J. Rad. Oncol. Biol. Phys. 15:1988;391-397.
30. Giaccia A. Hypoxic stress proteins Survival of the fittest . Sem. Rad. Oncol. 6:1996;46-58.
31. Graeber T., Osmanian C., Jacks T., Housman D., Koch C., Lowe S., Giaccia A. Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours. Nature. 379:(6560):1996;88-91.
32. Bristow R., Benchimol S., Hill R. The p53 gene as a modifier of intrinsic radiosensitivity implications for radiotherapy . Radiother. Oncol. 40:1996;197-223.
33. Koch W., Brennan J., Zahurak M., Goodman S., Westra W., Schwab D., Yoo G.H., Lee D.J.G., Forastiere A., Sidransky D. P53 mutation and locoregional treatment failure in head and neck squamous cell carcinoma. JNCI. 88:1996;1580-1586.
34. Dusenbery K., McGuire W., Holt P., Carson L., Fowler J.M., Twiggs L.B., Potish R.A. Erythropoietin increases hemoglobin during radiation therapy for cervical cancer. Int. J. Radiat. Oncol. Biol. Phys. 29:1994;1079-1084.
35. Lavey R., Dempsey W. Erythropoietin increases hemoglobin in cancer patients during radiation therapy. Int. J. Radiat. Oncol. Biol. Phys. 27:1993;1147-1152.